Condition

Hypertrophic Cardiomyopathy

Treatments and trials tagged Hypertrophic Cardiomyopathy, with the same country and access zoom as New Developments.

Hypertrophic Cardiomyopathy breakthroughs

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States Canada United Kingdom China European Union

New Pill When the Heart Muscle Is Too Thick

Myqorzo (aficamten) for obstructive hypertrophic cardiomyopathy

The FDA, Europe, the UK, and China have labelled aficamten for symptomatic obstructive HCM in adults. England's NHS has a 30-day funding clock from NICE.…

The FDA, Europe, the UK, and China have labelled aficamten for symptomatic obstructive HCM in adults.…

September 3, 2026